AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL

RecruitingNAAges 60 Years - 85 YearsAllSun Yat-Sen Memorial Hospital of Sun Yat-Sen Univโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study compares the hearing improvement effects of domestic hearing aids and imported hearing aids in 80 patients with moderate to severe and severe age-related hearing loss. Patients will be randomly assigned to either the experimental group (domestic hearing aids) or the control group (imported hearing aids) and will undergo a 30-minute trial. Pure Tone Average (PTA) and Speech Recognition Threshold (SRT) will be measured both before and after the trial. The improvements in PTA and SRT will be calculated.The market prices of the hearing aids and the degree of hearing improvement in decibels will be recorded. These data will be used to conduct a comprehensive cost-effectiveness analysis. After the trial, the International Outcome Inventory for Hearing Aids (IOI-HA) and the Abbreviated Profile of Hearing Aid Benefit (APHAB) will be used to assess the benefits of the hearing aids.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age โ‰ฅ 60 years and โ‰ค 85 years; 2. Diagnosed with age-related hearing Loss, which is characterized by bilateral, symmetrical, and gradually progressive hearing loss primarily affecting high frequencies, along with a decline in speech recognition ability, as referenced in the "Expert Consensus on Diagnosis and Intervention of Age-Related Hearing Loss" (2019 edition); 3. Age-related hearing Loss is of moderate to severe or severe sensorineural hearing loss, with moderate to severe defined as 50 to \<65 dB HL, and severe defined as 65 to \<80 dB HL; 4. Chinese nationality, able to complete all assessments in the Chinese language; 5. Right-handed; 6. No significant neurological diseases, severe systemic diseases, family history of genetic disorders, or major psychiatric conditions; Exclusion Criteria: 1. Exclusion of noise-induced hearing loss, hereditary hearing loss, drug-induced hearing loss, etc.; 2. Inability to use hearing aids ; 3. Presence of dementia, Parkinson's disease, or other neurodegenerative diseases that may affect study compliance; 4. History of cerebrovascular accidents, stroke, epilepsy, or other central nervous system disorders; 5. Other conditions deemed by the investigator to be exclusionary.
๐Ÿ’Š

What it tests

  • Domestic hearing aids
  • Imported hearing aids
๐Ÿ“

Where

1 site
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy